Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Global Jan-Sep...

    Global Jan-Sep healthcare IT VC funding hits $4.2 bn: Mercom

    Written by savita thakur thakur Published On 2016-10-20T12:35:31+05:30  |  Updated On 20 Oct 2016 12:35 PM IST
    Global Jan-Sep healthcare IT VC funding hits $4.2 bn: Mercom

    New Delhi : Global venture capital funding in the health IT sector totalled USD 1.25 billion in the September quarter this year, taking the year to date tally to USD 4.2 billion, says a report.


    So far this year, more than USD 4.2 billion has been raised through 463 deals, well ahead of the USD 3.6 billion raised during the same period in 2015.


    "International funding deals continue to be strong, especially in China, boosting the overall total. 2016 is on pace to be the best fund-raising year for the sector," Mercom Capital Group CEO and co-founder Raj Prabhu said.


    There were 17 Indian healthcare IT companies that received VC funding in the September quarter.


    Some notable Indian transactions in the September quarter were Bangalore-based CureFit mobilising USD 15 million in series A funding from Kalaari Capital, Accel Partners, and IDG Ventures and Mumbai-based HEAL Institute, raising up to USD 7.5 million from a group of investors, including Jaspal Bindra and Parth Jindal, son of JSW Group Chairman Sajjan Jindal.


    Globally, in the third quarter of this year, healthcare consumer-centric companies raised USD 851 million by way of 128 deals while healthcare practice-oriented companies secured 32 per cent of the funding with USD 404 million in 49 deals.


    The top funded areas were mHealth apps with USD 253 million, telemedicine (USD 220 million), practice management solutions (USD 82 million), consulting (USD 77 million), mobile wireless (USD 75 million), wearables and sensors (USD 74 million), remote monitoring (USD 65 million) and payer solutions (USD 50 million).


    The report noted that there were 53 M&A transactions involving healthcare IT companies in the September quarter.


    The top disclosed M&A deal was the USD 2.35 billion acquisition of Press Ganey Associates by EQT Equity fund EQT VII, the report said.

    globalGlobal ventureHealthcareIDG VenturesRaj PrabhuVC funding
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok